Brainlab

Bold Leadership for a New Era: ulrich medical USA® Welcomes Jim Bruty as Chief Executive Officer to Build Upon its Legacy of Innovation

Retrieved on: 
Wednesday, January 24, 2024

"We are thrilled to welcome Jim into this new role," said Klaus Kiesel, Chairman of the Board of Directors, ulrich medical USA and Chief Executive Officer, ulrich medical.

Key Points: 
  • "We are thrilled to welcome Jim into this new role," said Klaus Kiesel, Chairman of the Board of Directors, ulrich medical USA and Chief Executive Officer, ulrich medical.
  • Mr. Bruty joined ulrich medical USA with an impressive track record of success in the orthopedic and spine sectors.
  • "I am honored to lead ulrich medical USA and build upon its legacy of excellence," commented Mr. Bruty.
  • Mr. Bruty succeeds Hans Stover, who played a crucial role in establishing a foundation of growth and profitability for ulrich medical USA over his 14-year tenure.

Icelandair Drives 10x ROI improvement and 70% Reduction in Cost Per Booking in Digital Media with Scibids AI and Brainlabs

Retrieved on: 
Wednesday, September 20, 2023

Scibids , the global leader in artificial intelligence (AI) for digital marketing, announces a collaboration with Icelandair and its digital media agency, Brainlabs.

Key Points: 
  • Scibids , the global leader in artificial intelligence (AI) for digital marketing, announces a collaboration with Icelandair and its digital media agency, Brainlabs.
  • By leveraging Scibids’ customizable AI, Brainlabs has achieved exceptional results for Icelandair’s programmatic ad campaigns.
  • “The results were incredibly fruitful for Icelandair, with Scibids AI and Brainlabs securing a 70% decrease in cost per flight booking over the past year,” said Jóhann Benediktsson, Digital Marketing Manager, Icelandair.
  • “This level of efficiency represents a 10x ROI for the brand compared to the benchmark price of applying artificial intelligence ourselves.

Falfurrias Capital Partners Announces Growth Investment in Brainlabs

Retrieved on: 
Monday, September 18, 2023

CHARLOTTE, N.C., Sept. 18, 2023 /PRNewswire/ -- Falfurrias Capital Partners (FCP), a private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Brainlabs, an internationally acclaimed full-service media agency. The agency is renowned for its 'high-performance' approach to media, to deliver measurable and profitable business impact to brands worldwide, powered by data and technology.

Key Points: 
  • CHARLOTTE, N.C., Sept. 18, 2023 /PRNewswire/ -- Falfurrias Capital Partners (FCP), a private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Brainlabs , an internationally acclaimed full-service media agency.
  • In the four years since, the agency has seen top line growth of 800% and integrated eight strategic acquisitions.
  • Falfurrias Capital Partners' Alexander Jutkowitz, Geordie Pierson, and Joe Price, as well as the Ad Council's Lisa Sherman will join the company board.
  • "With our extensive experience in the marketing and media space, Brainlabs is a perfect fit for Falfurrias," said Geordie Pierson, Partner at Falfurrias Capital Partners.

ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing

Retrieved on: 
Thursday, August 17, 2023

WESTMINSTER, Colo., Aug. 17, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has expanded its cooperation agreement with Brainlab, an innovation leader with an expansive and diversified spine imaging, planning, and navigation portfolio, as well as robotic imaging, surgical assistance, and mixed reality to support spinal surgeries.

Key Points: 
  • ZimVie and Brainlab have started a joint project to achieve compatibility between ZimVie’s Vital and Virage fixation systems and Brainlab spine and trauma navigation technologies, which help surgeons plan and execute spinal procedures, accurately place pedicle screws, and minimize radiation exposure.
  • In addition, ZimVie will co-market the Brainlab spine and trauma navigation technologies alongside its existing spine implant solutions globally.
  • “We are excited to partner with Brainlab to bring into the operating room differentiated technology aiming at enhancing workflow and accuracy for surgeons and staff,” said Vafa Jamali, President and Chief Executive Officer of ZimVie.
  • “We have been focused on expanding our portfolio with enabling technology to drive greater adoption across our spine portfolio.

Radiation therapy treatment rates show improved efficiency, finds New IMV Market Summary Report

Retrieved on: 
Thursday, June 22, 2023

But these particular data points in the report -- called the IMV 2022-2023 Radiation Therapy Market Summary – reflect a gain in the efficiency of treating patients with radiation therapy, in part due as well to a 5.4% decrease in the average number of visits per course of treatment, report lead and IMV senior market research program manager Davin Korstjens said.

Key Points: 
  • Reduced Number of Patient Visits Needed per Course of Radiation Therapy Treatment, according to a recent IMV's 2022-2023 Radiation Therapy Market Summary report.
  • But these particular data points in the report -- called the IMV 2022-2023 Radiation Therapy Market Summary – reflect a gain in the efficiency of treating patients with radiation therapy, in part due as well to a 5.4% decrease in the average number of visits per course of treatment, report lead and IMV senior market research program manager Davin Korstjens said.
  • The report also found that, although the external beam radiation therapy installed base in the U.S. decreased by 3.3% in 2022, 50% of radiation therapy sites are considering the purchase of an EBRT system in the next three years, Korstjens said.
  • IMV's 2022-2023 Radiation Therapy Market Summary Report explores market trends in U.S. hospitals and imaging centers, including procedure volume, manufacture-installed base features and share, the use of OEM vs. third-party service providers, purchase plans, brand loyalty, and site operations characteristics.

Brainlab and the AO Foundation Collaborate on the Future of Immersive Medical Education and Training

Retrieved on: 
Thursday, June 22, 2023

Brainlab , a digital medical technology company, announced today an expanded collaboration outlining initiatives in their ongoing work with the AO Foundation .

Key Points: 
  • Brainlab , a digital medical technology company, announced today an expanded collaboration outlining initiatives in their ongoing work with the AO Foundation .
  • View the full release here: https://www.businesswire.com/news/home/20230621121553/en/
    Brainlab, the AO Foundation and Level Ex sign an agreement at the AO Trustees Meeting, June 22 in Sydney, Australia.
  • Left to right: Sam Glassenberg, CEO, Level Ex; Prof. Dr. Florian Gebhard, President, AO Foundation; Christoph Lindenmeyer, CEO, AO Foundation; Nils Ehrke, EMEA President, Brainlab.
  • The AO plans to introduce this workflow and associated technology into certain activities within the AO Education Institute and the AO Technical Commission.

ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Wednesday, March 1, 2023

Both segments were unfavorably impacted by one less selling day in the fourth quarter of 2022.

Key Points: 
  • Both segments were unfavorably impacted by one less selling day in the fourth quarter of 2022.
  • Adjusted net income[1] for the fourth quarter of 2022 was $4.3 million, an increase of $13.6 million versus the same prior year period.
  • Basic and diluted EPS were ($1.16) and adjusted diluted EPS[1] was $0.16 for the fourth quarter of 2022.
  • Adjusted EBITDA[1] for the fourth quarter of 2022 was $28.1 million, or 12.3%, a 70 basis point increase from the fourth quarter of 2021.

Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs

Retrieved on: 
Monday, February 27, 2023

“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany.

Key Points: 
  • “This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany.
  • Lucy has previously provided naturally-derived N.N-dimethyltryptamine (DMT) to the Brain Lab and Biological Psychiatry Department at Hadassah-Hebrew University.
  • "We extend our sincerest gratitude to LSDI for their efforts in our research endeavors,” said Dr. Bernard Lerer, Professor of Psychiatry and Director of Hadassah BrainLabs.
  • “Their provision of a variety of psychedelic compounds has been instrumental in advancing our scientific understanding and opening new avenues for discovery.

Insights on the Robotic Radiosurgery System Global Market to 2028 - Size, Share, & COVID-19 Impact Analysis - ResearchAndMarkets.com

Retrieved on: 
Friday, December 23, 2022

The global robotic radiosurgery market experienced a substantial increase in the number of procedures performed in 2021.

Key Points: 
  • The global robotic radiosurgery market experienced a substantial increase in the number of procedures performed in 2021.
  • In 2020, the market undertook a slower growth in procedure volume as a result of the Global COVID-19 pandemic.
  • The Global Robotic Radiosurgery System market has only one dominant competitor: Accuray.
  • While there are some other radiosurgery systems on the market with robotic components, Accuray's CyberKnife is the only true robot on the market.

Global Neurosurgery Navigation Systems Market Report 2022: Featuring Brainlab, Stryker, ANT Neuro and ClaroNav Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 21, 2022

In 2021, the global neurosurgery navigation system market experienced a prominent increase in the number of procedures performed.

Key Points: 
  • In 2021, the global neurosurgery navigation system market experienced a prominent increase in the number of procedures performed.
  • A continuing trend in the global neurosurgery navigation market is that it is mainly a replacement and upgrade market, especially in more developed regions like North America, where the market is mature.
  • The global neurosurgery navigation system market has three dominant competitors: Medtronic, Brainlab, and Stryker.
  • Medtronic led the global neurosurgery navigation system market in 2021.